CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk
Clinical trial NCT07615348 · RECRUITING
Trial details
- NCT number
- NCT07615348
- Sponsor
- Jinling Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-16
- Primary completion
- 2028-08-10
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.